Search

Your search keyword '"Tsuji, Moriya"' showing total 540 results

Search Constraints

Start Over You searched for: Author "Tsuji, Moriya" Remove constraint Author: "Tsuji, Moriya"
540 results on '"Tsuji, Moriya"'

Search Results

1. New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19

2. SARS-CoV-2 RNA Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection

3. MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis.

4. Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines

5. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria

8. Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines.

9. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria

10. An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

12. Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines

16. A pancreatic cancer mouse model with human immunity

20. Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells.

23. Supplementary Figure 3 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

24. Supplementary Legends 1-5, Table 1, Methods from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

26. Supplementary Figure 4 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

27. Supplementary Figure 5 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

28. Supplementary Figure 1 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

29. Supplementary Figure 2 from Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice

31. Diversity of HLA-A2-Restricted and Immunodominant Epitope Repertoire of Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Protein: Novel Insights among N-Terminal, Central and C-Terminal Regions

32. An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo

36. Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination

37. In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns

38. The role of mucosal-associated invariant T cells in visceral leishmaniasis

39. Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate

40. An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo

41. KLRG⁺ invariant natural killer T cells are long-lived effectors

43. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses

44. Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium

45. Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination

46. Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice.

47. Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient

50. Isolation and comparative analysis of antibodies that broadly neutralize sarbecoviruses

Catalog

Books, media, physical & digital resources